Pneumothorax Treatment Devices Market Outlook 2026–2035: Growth Drivers and Industry Forecast

Global Pneumothorax Treatment Devices Market

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Pneumothorax Treatment Devices Market?

The pneumothorax treatment devices market has experienced rapid expansion in recent years. It is forecast to grow from $3.98 billion in 2025 to $4.39 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.3%. Historically, this growth can be attributed to several factors including an increase in traumatic chest injuries, a rise in road accident cases, the development of hospital emergency infrastructure, the adoption of chest tube procedures, and the expansion of critical care units.

The market for pneumothorax treatment devices is projected to experience substantial expansion over the coming years. This market is anticipated to reach $6.43 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.0%. Factors contributing to this growth during the projection period include the rise in portable emergency devices, improvements in thoracic vent systems, a greater number of ICU admissions, the necessity for quicker lung re-expansion, and the expansion of emergency medical services. Key trends expected during the forecast period encompass rapid emergency lung decompression, portable pneumothorax management devices, minimally invasive chest drainage, enhanced air leak control systems, and simplified bedside treatment kits.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20929&type=smp

Which Drivers Are Supporting The Rise Of The Pneumothorax Treatment Devices Market?

The pneumothorax treatment devices market is projected to expand due to the rising prevalence of respiratory diseases. These medical conditions affect the lungs and airways, thereby impairing breathing and the exchange of oxygen. The increase in respiratory illnesses can be attributed to various factors such as air pollution, smoking, viral infections, and heightened exposure to allergens. Pneumothorax treatment devices are utilized in such diseases to manage collapsed lungs and restore normal breathing function. For example, according to the Australian Bureau of Statistics, an Australia-based government agency, in September 2025, deaths related to influenza climbed from 611 deaths in 2023 to 806 deaths in 2024, further increasing to 1,057 deaths in the year to August 2025, marking a 73% rise from 2023 to the comparable August 2025 period. Fatalities involving respiratory syncytial virus (RSV) also escalated from 380 deaths in 2023 to 468 deaths in 2024 and 399 deaths in the year to August 2025. Thus, the escalating incidence of respiratory diseases acts as a key driver for the growth of the pneumothorax treatment devices market.

What Segments Are Identified Within The Structure Of The Pneumothorax Treatment Devices Market?

The pneumothorax treatment devices market covered in this report is segmented –

1) By Type: Ventilator Devices, Thoracic Vent Devices, Other Types

2) By Application: Traumatic Pneumothorax, Spontaneous Pneumothorax, Other Applications

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Ventilator Devices: Portable Ventilators, Non-Invasive Ventilators, Invasive Ventilators

2) By Thoracic Vent Devices: Chest Drainage Systems, Heimlich Valves, One-Way Chest Valve Systems

3) By Other Types: Needle Aspiration Devices, Pleural Catheters, Oxygen Therapy Devices

What Industry Trends Are Transforming The Pneumothorax Treatment Devices Market?

Major companies operating within the pneumothorax treatment devices market are prioritizing the development of technologically advanced offerings, such as chest X-ray solutions, to sustain their market position. Chest X-ray solutions refer to sophisticated imaging systems, equipment, and technologies designed to capture detailed radiographic images of the chest, encompassing the lungs, heart, ribs, and surrounding anatomical structures. For instance, in September 2023, Qure.ai, a US-based health tech company, announced it had received 510(k) FDA clearance for its innovative chest X-ray solution, qXR-PTX-PE. This solution is specifically designed to assist in the rapid detection of pneumothorax (PTX) and pleural effusion (PE). The AI-enabled software enhances patient care pathways in intensive care units (ICUs) and emergency rooms (ERs) by providing timely notifications to healthcare professionals. The qXR-PTX-PE solution meticulously analyzes chest X-ray images for critical findings, significantly improving triage efficiency in emergency settings where these conditions pose considerable risks to patient health.

Which Key Market Players Are Investing In Expansion And Innovation Within The Pneumothorax Treatment Devices Market?

Major companies operating in the pneumothorax treatment devices market are Cardinal Health Inc., Medtronic PLC, Siemens Healthineers AG, Medline Industries Inc., Fujifilm Holdings Corporation, Becton Dickinson and Company (BD), GE HealthCare Technologies Inc., Stryker Corporation, Boston Scientific Corporation, Draegerwerk AG & Co. KGaA, Cook Medical Inc., B. Braun Melsungen AG, Utah Medical Products Inc., Rocket Medical plc, Nobelpharma Co. Ltd., Sinapi Biomedical Inc., UreSil Inc., ATMOS MedizinTechnik GmbH & Co. KG, Betaglue Technologies S.p.A., Selio Medical Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pneumothorax-treatment-devices-global-market-report

Which Regions Are Projected To Dominate The Pneumothorax Treatment Devices Market In The Coming Years?

North America was the largest region in the pneumothorax treatment devices market in 2025. The regions covered in the pneumothorax treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pneumothorax Treatment Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20929&type=smp

Browse Through More Reports Similar to the Global Pneumothorax Treatment Devices Market 2026, By The Business Research Company

Pneumococcal Vaccine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pneumococcal-vaccine-global-market-report

Respiratory Devices And Equipment Therapeutic Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-global-market-report

Respiratory Devices And Equipment Therapeutic And Diagnostic Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-and-diagnostic-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company